Literature DB >> 596125

The cerebrovascular permeability to protein after bicuculline and amphetamine administration in spontaneously hypertensive rats. Evidence for increased resistance of pressure-induced blood-brain barrier dysfunction.

B B Johansson.   

Abstract

Hemodynamic and morphometric studies on spontaneously hypertensive rats (SHR) have suggested that the lumen to wall ratio of the resistance vessels is decreased due to hypertrophy of the media. As the tension in the vessel wall increases with the pressure and the radius and decreases with the vessel wall thickness, such vessels would be expected to withstand higher pressure than vessels of normotensive rats (NR) unless local wall defects were present. Bicuculline-induced epileptic activity and amphetamine intoxication, two conditions with cerebral vasodilatation and high blood pressure, give rise to extensive protein leakage in the brain of NR. Consistent with the hypothesis presented above, less protein leakage occurred in brains of SHR than in brains of NR after amphetamine and bicuculline administration.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 596125     DOI: 10.1111/j.1600-0404.1977.tb01447.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Ultrastructural and permeability characteristics of retinal vessels in stroke-prone spontaneously hypertensive rats.

Authors:  W L Lin; E Essner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

2.  Increase of adenosine content in cerebral cortex of the cat during bicuculline-induced seizure.

Authors:  J Schrader; M Wahl; W Kuschinsky; G W Kreutzberg
Journal:  Pflugers Arch       Date:  1980-09       Impact factor: 3.657

3.  Hypertension and brain oedema: an experimental study on acute and chronic hypertension in the rat.

Authors:  B B Johansson; L E Linder
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.